Merit Financial Group, LLC Bristol Myers Squibb CO Transaction History

Merit Financial Group, LLC

  • $4.59 Billion
  • Q3 2024

A detailed history of Merit Financial Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Merit Financial Group, LLC holds 31,639 shares of BMY stock, worth $1.84 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
31,639
Previous 19,902 58.97%
Holding current value
$1.84 Million
Previous $826,000 98.18%
% of portfolio
0.04%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
BUY
$39.66 - $51.75 $465,489 - $607,389
11,737 Added 58.97%
31,639 $1.64 Million
Q2 2024

Aug 13, 2024
SELL
$40.25 - $52.99 $769,177 - $1.01 Million
-19,110 Reduced 48.98%
19,902 $826,000
Q1 2024

May 06, 2024
BUY
$47.98 - $54.4 $911,044 - $1.03 Million
18,988 Added 94.83%
39,012 $2.12 Million
Q4 2023

Feb 06, 2024
SELL
$48.48 - $57.85 $1.23 Million - $1.47 Million
-25,473 Reduced 55.99%
20,024 $1.03 Million
Q3 2023

Nov 07, 2023
SELL
$57.89 - $64.73 $54,937 - $61,428
-949 Reduced 2.04%
45,497 $2.64 Million
Q2 2023

Aug 01, 2023
SELL
$63.71 - $70.74 $15,417 - $17,119
-242 Reduced 0.52%
46,446 $2.97 Million
Q1 2023

Apr 24, 2023
SELL
$65.71 - $74.53 $395,705 - $448,819
-6,022 Reduced 11.42%
46,688 $3.24 Million
Q4 2022

Jan 13, 2023
BUY
$68.48 - $81.09 $1.53 Million - $1.81 Million
22,285 Added 73.25%
52,710 $0
Q3 2022

Oct 31, 2022
SELL
$0.13 - $76.84 $1,523 - $900,564
-11,720 Reduced 27.81%
30,425 $2.16 Million
Q2 2022

Aug 08, 2022
BUY
$72.62 - $79.98 $2.58 Million - $2.84 Million
35,493 Added 533.57%
42,145 $3.25 Million
Q1 2022

May 13, 2022
SELL
$61.48 - $73.72 $539,917 - $647,409
-8,782 Reduced 56.9%
6,652 $486,000
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $4,075 - $4,751
-76 Reduced 0.49%
15,434 $962,000
Q3 2021

Oct 27, 2021
BUY
$59.17 - $69.31 $5,206 - $6,099
88 Added 0.57%
15,510 $918,000
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $74,911 - $81,578
-1,210 Reduced 7.28%
15,422 $1.03 Million
Q1 2021

May 18, 2021
BUY
$59.34 - $66.74 $570,672 - $641,838
9,617 Added 137.09%
16,632 $1.05 Million
Q4 2020

Feb 12, 2021
BUY
$57.74 - $65.43 $51,850 - $58,756
898 Added 14.68%
7,015 $435,000
Q3 2020

Nov 10, 2020
SELL
$57.43 - $63.64 $29,633 - $32,838
-516 Reduced 7.78%
6,117 $369,000
Q2 2020

Aug 13, 2020
BUY
$54.82 - $64.09 $58,712 - $68,640
1,071 Added 19.26%
6,633 $390,000
Q1 2020

May 05, 2020
BUY
$46.4 - $67.43 $78,137 - $113,552
1,684 Added 43.42%
5,562 $310,000
Q4 2019

Jan 16, 2020
BUY
$49.21 - $64.19 $190,836 - $248,928
3,878 New
3,878 $249,000

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email